Cohort of Respiratory Failure Patients Treated for the First Time With Non-Invasive Ventilation at Home

NCT ID: NCT02346305

Last Updated: 2023-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effectiveness of NIV is clearly demonstrated but no recent studies describe the prescription based on clinical data and the conditions of using NIV at home according the various respiratory diseases.

The investigators' purpose is that a better knowledge of NIV practices could improve both the quality to support patients at home and the efficacy of the treatment.

The main objective of this study is to analyze the clinical data justifying the prescription of NIV advice according respiratory disease. The secondary objectives are to study comorbidities, treatment failures, survival rate during the study period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-invasive ventilation

Home NIV installation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No previous experience with domiciliary non-invasive ventilation
* Adult patients, ≥ 18 years of age
* Without tracheotomy
* No evolutive cancer
* No significant psychiatric disease
* Possible medical monitoring

Exclusion Criteria

* Evolutive cancer
* Inability to understand rationale and/or consent form for study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudio RABEC, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire Dijon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU d'Angers

Angers, , France

Site Status NOT_YET_RECRUITING

CHU de Besançon

Besançon, , France

Site Status NOT_YET_RECRUITING

CH de Cannes

Cannes, , France

Site Status NOT_YET_RECRUITING

CHU de Dijon

Dijon, , France

Site Status RECRUITING

Garches

Garches, , France

Site Status NOT_YET_RECRUITING

CHU de Grenoble

Grenoble, , France

Site Status NOT_YET_RECRUITING

CHD de la Réunion

La Réunion, , France

Site Status NOT_YET_RECRUITING

CHU de Lille

Lille, , France

Site Status NOT_YET_RECRUITING

CHU de Limoges

Limoges, , France

Site Status NOT_YET_RECRUITING

CHU de Nancy

Nancy, , France

Site Status NOT_YET_RECRUITING

AP-HP Pitié-Salpêtrière

Paris, , France

Site Status NOT_YET_RECRUITING

Hôpital Edouard Rist

Paris, , France

Site Status NOT_YET_RECRUITING

CHU de Rouen

Rouen, , France

Site Status RECRUITING

CHU de Rouen

Rouen, , France

Site Status NOT_YET_RECRUITING

CHU de Strasbourg

Strasbourg, , France

Site Status NOT_YET_RECRUITING

CHU de Toulouse

Toulouse, , France

Site Status NOT_YET_RECRUITING

Hôpital Robert Schuman

Vantoux, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Didier FORET

Role: CONTACT

33 (1) 56 81 40 60

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Frédéric GAGNADOUX, Pr

Role: primary

Frédéric CLAUDE, MD

Role: primary

Christophe PERRIN, MD

Role: primary

Claudio RABEC, MD

Role: primary

Hélène PRIGENT, MD

Role: primary

Jean-Louis PEPIN, Pr

Role: primary

Ziad RIDA, MD

Role: primary

Anne MALLART, MD

Role: primary

Boris MELLONI, Pr

Role: primary

François CHABOT, Pr

Role: primary

Jésus GONZALEZ, MD

Role: primary

Franck LAVERGNE, MD

Role: primary

Antoine CUVELIER, Pr

Role: primary

Jean-François MUIR, Pr

Role: primary

Romain KESSLER, Pr

Role: primary

Sandrine PONTIER, MD

Role: primary

Pierre CERVANTES, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014 - NIV - 14734

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NIV for COPD: Hospital to Home
NCT04413643 TERMINATED NA